Creating a Device Around Headache
Benjamin Pless, CEOAutonomic Technologies, Inc.
North America Neuromodulation Society I3 SessionLas Vegas, December 2012
Dec 6, 2012Autonomic Technologies
Not For Distribution1
Autonomic Technologies Not For Distribution
2007(March): The beginning• Cleveland Clinic
presentation to KPCB of autonomic patents to control a wide range of disorders– Headache– Vascular– Cardiac– Pulmonary– Renal
Dec 6, 2012 2
SPG is a known therapeutictarget to treat headache
• SPG interventions have a long history in the treatment of Migraine and Cluster Headache– Anesthetic trans-nasal topical
blocks– Drug injection blocks– Pulsed RF and ablative blocks– Surgical procedures including
gamma knife
• Acute interventions have been reported sometimes to provide weeks of sustained pain relief
3Dec 6, 2012
Autonomic Technologies Not For Distribution
Acute SPG Stimulation
Dec 6, 2012Autonomic Technologies
Not For Distribution4
Early Proof of Concept research at the Cleveland Clinic by physician inventors demonstrating ability of stimulation to stop cluster headaches
Dec 6, 2012Autonomic Technologies
Not For Distribution5
Sphenopalatine Ganglion (aka Pterygopalatine Ganglion) – a closer look
Dec 6, 2012Autonomic Technologies
Not For Distribution6
R.L. Drake, Grays Anatomy for Students, 2005
Dec 6, 2012Autonomic Technologies
Not For Distribution7
ATI Product Considerations
• Good cosmesis – majority of patients are women
• Minimally invasive implant– Difficult surgery would reduce acceptability
• Simple and easy explant– “no harm, no foul” lowers barriers to acceptance
Dec 6, 2012Autonomic Technologies
Not For Distribution8
Prior Neurostimulator Paradigm
Dec 6, 2012Autonomic Technologies
Not For Distribution9
Early ATI Product Concept
Dec 6, 2012Autonomic Technologies
Not For Distribution10
Patient Experiences of Tunneling
Dec 6, 2012Autonomic Technologies
Not For Distribution11
Surgical Retreat August 2008
• ATI dissatisfaction with invasiveness of approach
• Included variety of – Neurosurgeons– ENTs– Plastic surgeons– CMF
Dec 6, 2012Autonomic Technologies
Not For Distribution12
Dec 6, 2012Autonomic Technologies
Not For Distribution13
Gingival Buccal Approach to the SPG
Adopted by ATI
Developed by: Dr. Frank Papay,Cleveland Clinic, Cleveland Ohio
Dec 6, 2012Autonomic Technologies
Not For Distribution14
New ATI Neurostimulator Concept
Dec 6, 2012Autonomic Technologies
Not For Distribution15
Stimulating probe neurostimulator Fixation bracket
• No battery• Patient activated
The procedure begins by doing a submucosal injection of a vasoconstrictor and local anesthesic. An 1-2 cm incision is made approximately 3 to 5 mm superior to the mucogingival junction.
Dec 6, 2012Autonomic Technologies
Not For Distribution16
Upper Lip
Mucosa Incision
Periosteal elevators are used to elevate the tissue in the subperiosteal plane. Dissect the tissue until the inferior aspect of the zygomaticomaxillary buttress area is exposed, also called the zygomatic process of the maxilla.
Dec 6, 2012Autonomic Technologies
Not For Distribution17
Mucosa
The proprietary ATI introducer is then inserted subperiosteally behind the zygomaticomaxillary buttress, and advanced on the posterior side of the maxillary sinus to the pterygopalatine fossa.
Dec 6, 2012Autonomic Technologies
Not For Distribution18
ATI introducer
The neurostimulator is then placed in the PPF either by using the introducer as a guide, and sliding the neurostimulator probe between the bone and introducer, or by removing the introducer and placing the neurostimulator probe into the dissection path created by the introducer.
Dec 6, 2012Autonomic Technologies
Not For Distribution19
ATI neurostimulator
ATI neurostimulator Implantation
20
Neurostimulator lead within the pterygopalatine fossa
Neurostimulator lead in the pterygopalatine fossa stimulates the sphenopalatine
ganglion (SPG)
Dec 6, 2012Autonomic Technologies
Not For Distribution
Autonomic TechnologiesSPG Stimulator for Headache
• Simple therapy controls:on/off and up/down
• Wirelessly powers and controls Neurostimulator
21
On-demand,
patient-controlled therapy
• Implantable Neurostimulator
• Miniaturized• Minimally invasive
• CE Marked• Investigational use
only in the US
Dec 6, 2012Autonomic Technologies
Not For Distribution
Acute Response to SPG Stimulation
Dec 6, 2012Autonomic Technologies
Not For Distribution22
Special Thanks to Physician Collaborators
• Frank Papay• Stew Tepper• Ali Rezai• Samer Narouz• Mehdi Ansarinia• Joseph Roberson• Michael Stanton-Hicks• Peter Goadsby
• Richard Lipton• Jean Schoenen• Rigmor Jensen• Arne May• Soren Hillerup• Stephen Silberstein• Miguel Lainez• …and many more!!!
Dec 6, 2012Autonomic Technologies
Not For Distribution23
Thank You!
Dec 6, 2012Autonomic Technologies
Not For Distribution24